Can probiotics during antibiotic treatment be personalized based on baseline gut ecology?

Do probiotics reliably restore your gut's bacterial diversity during antibiotics?

The most comprehensive evidence says no. A 2023 systematic review and meta-analysis of 15 randomized controlled trials found that taking probiotics alongside antibiotics did not significantly improve any measure of gut microbiome diversity — including the Shannon index (a standard measure of species richness and evenness) and the Chao1 index (which estimates total species count) [2]. The authors concluded that probiotic supplementation during antibiotic therapy was 'not found to be influential on gut microbiome diversity indices.' This means that for the average person, adding a probiotic does not reliably prevent the drop in bacterial variety that antibiotics cause.

This finding is echoed in other settings. A 2021 study in newborns given antibiotics found that probiotics did not restore overall gut diversity, though early use alongside antibiotics did help boost levels of beneficial Bifidobacterium bacteria compared to waiting until after antibiotics [5]. Similarly, a 2024 study in honeybees — a very different model, but one that allows controlled experiments — found that probiotics had no effect on gut microbiome recovery after antibiotics [4]. Together, these studies suggest that while probiotics may shift specific bacterial groups, they do not broadly restore the ecosystem to its pre-antibiotic state.

Can probiotics still help even if they don't restore diversity?

Yes, but the benefits appear to be specific and situational rather than a universal 'reset' of your gut. The strongest evidence for a targeted benefit comes from a 2021 randomized controlled trial in 120 elderly hospital patients (average age 78) on amoxicillin-clavulanate antibiotics [1]. Patients who took a specific probiotic mix (Saccharomyces boulardii plus strains of Lactobacillus and Bifidobacterium) for 30 days saw colonization with dangerous Pseudomonas bacteria drop from 25% to 8.3% — a two-thirds reduction. They also had fewer infections with ESBL-producing bacteria (a type of antibiotic-resistant superbug) over the next two years. This suggests probiotics can act as a shield against specific pathogens, even if they don't restore overall diversity.

A 2025 study in dogs — which are closer to humans than honeybees — found that a probiotic complex given for two weeks after a single antibiotic injection significantly increased alpha-diversity (a measure of within-sample bacterial richness) compared to dogs that got no probiotics [3]. The probiotic group also had higher levels of Butyricicoccus, a beneficial butyrate-producing bacterium, and lower levels of Clostridioides, a marker of antibiotic-induced dysbiosis. This indicates that in some contexts, probiotics can help maintain a healthier bacterial community structure, though the effect may depend on the specific probiotic strains and the antibiotic used.

Why can't we personalize probiotics based on your baseline gut ecology?

The core problem is that no study has yet tested whether tailoring a probiotic to a person's starting gut bacteria improves outcomes. All the available trials use fixed, off-the-shelf probiotic mixtures — they do not adjust the strains or doses based on an individual's baseline microbiome. The 2023 meta-analysis noted that there was 'high variability across the studies regarding the indication of antibiotic therapy and the type, dose, and duration of antimicrobials and probiotics,' making it impossible to draw conclusions about personalized approaches [2].

Furthermore, the evidence shows that the effect of probiotics is highly context-dependent. The same probiotic mix that reduced Pseudomonas colonization in elderly hospital patients [1] might not work in a younger, healthier person with a different baseline gut ecology. The honeybee study [4] and the newborn study [5] both found that probiotics had no effect on overall diversity, but the newborn study did find that timing mattered — giving probiotics alongside antibiotics was better than waiting. This suggests that factors like age, antibiotic type, and timing may be more important than baseline ecology, but we don't yet know how to combine these factors into a personalized prescription. Until researchers conduct trials that randomize patients to probiotics matched to their baseline microbiome versus a standard probiotic, personalization remains an unproven concept.

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2021 to 2025, 2 from 2024 or later, 4 in Q1 journals, collectively cited 174 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 58 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions